Financhill
Back

4D Molecular Therapeutics Stock Predictions

One Tool. Personalized Setups.

Try it here.
Sell
47

FDMT
4D Molecular Therapeutics

Last Price:
$4.21
Seasonality Move:
-13.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Built for Lazy Summer Markets

Get instant access today.

4D Molecular Therapeutics Stock Forecast

  • Is 4D Molecular Therapeutics Stock Undervalued?
    The current 4D Molecular Therapeutics [FDMT] share price is $4.24. The Score for FDMT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will 4D Molecular Therapeutics Stock Go Up Next Year?

Data Unavailable

4D Molecular Therapeutics Stock Rating

Data Unavailable

4D Molecular Therapeutics Stock Price History

Is FDMT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDMT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
4dmoleculartherapeutics.com

52-Week Data

52-Week High:
28.93
52-Week Low:
2.24

Prediction Charts

Market Cap:
196.4M
Price in USD:
4.24
Volume:
196.3K
Beta:
2.85

Technical Analysis

SMA50:
3.74
SMA100:
3.83
SMA200:
5.94
52-Wk Change:
-79.66%

Stock Predictions

  • Is 4D Molecular Therapeutics stock public?
    Yes, 4D Molecular Therapeutics is a publicly traded company.
  • What is the 4D Molecular Therapeutics stock quote today?
    The 4D Molecular Therapeutics stock price is 4.24 USD today.
  • How to buy 4D Molecular Therapeutics stock online?
    You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 4.42 4.39 4.62 4.35
Jun-16 4.44 4.37 4.51 4.28
Jun-17 4.29 4.15 4.39 4.12
Jun-18 4.13 4.09 4.26 4.05
Jun-20 4.15 4.13 4.23 4.05
Jun-23 4.14 3.77 4.17 3.73
Jun-24 3.84 4.00 4.02 3.75
Jun-25 4.01 4.08 4.13 3.80
Jun-26 4.10 4.07 4.11 3.90
Jun-27 4.01 3.84 4.09 3.80
Jun-30 3.86 3.71 3.89 3.71
Jul-1 3.80 4.15 4.19 3.68
Jul-2 4.15 4.31 4.40 4.15
Jul-3 4.31 4.24 4.34 4.13

4D Molecular Therapeutics Earnings

Data Unavailable

4D Molecular Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.28 per share.

* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.